An Extension Study in Subjects With Plaque Psoriasis
Phase of Trial: Phase III
Latest Information Update: 11 Jul 2019
At a glance
- Drugs Brodalumab (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Kyowa Hakko Kirin
- 23 Jul 2015 Results published in a Kyowa Hakko Kirin media release.
- 24 Mar 2015 Efficacy and tolerability at 1-year results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
- 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.